+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Fibrin Sealant Kit Market - Global Forecast 2026-2032- Product Image
Human Fibrin Sealant Kit Market - Global Forecast 2026-2032- Product Image
Sale

Human Fibrin Sealant Kit Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6141634
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Fibrin Sealant Kit Market is projected to reach USD 1.52 Billion in 2026. It is expected to continue growing at a CAGR of 12.16%, reaching USD 3.02 Billion by 2032.

Human Fibrin Sealant Kits: Executive Summary

Human fibrin sealant kits are topical surgical hemostatic products that combine fibrinogen and thrombin to support clot formation and tissue adhesion. Their clinical relevance is strongest where conventional suturing, stapling, electrocautery, or compression is difficult, including minimally invasive, cardiovascular, hepatic, orthopedic, trauma, and reconstructive procedures. Adoption is shaped by clinical evidence, regulatory authorization, blood-derived material controls, preparation requirements, storage conditions, reimbursement, and hospital procurement protocols.

Clinical Integration Is Reshaping Hemostasis Practice

The landscape is shifting toward procedure-specific hemostasis, minimally invasive workflows, and products that can be applied rapidly in anatomically complex fields. Hospitals increasingly assess sealants alongside broader blood-management programs, emphasizing reduced blood loss, efficient operating-room use, predictable handling, and compatibility with multidisciplinary surgical pathways. These shifts also increase scrutiny of training, cold-chain reliability, traceability, infection-control procedures, and appropriate-use criteria.

Artificial Intelligence Strengthens Selection, Workflow, and Evidence Review

Artificial intelligence can support this field by analyzing clinical records, imaging, and procedural data to identify patients or surgical contexts with elevated bleeding risk. In hospital operations, AI may help coordinate inventory, monitor storage conditions, predict replenishment needs, and identify deviations from preparation protocols. Its value remains dependent on representative data, prospective validation, clinician oversight, cybersecurity, and clear separation between decision support and autonomous treatment recommendations.

Regional Insights Across Six Healthcare Environments

North America is characterized by sophisticated surgical infrastructure, stringent blood-product governance, and strong emphasis on evidence, reimbursement, and hospital value analysis. Europe combines harmonized regulatory principles with country-level procurement and reimbursement differences. Asia-Pacific presents diverse adoption conditions, ranging from advanced tertiary-care systems to settings where affordability, specialist availability, and distribution reliability are decisive. Latin America is influenced by uneven access to specialist surgery, public-private healthcare differences, and import requirements. The Middle East is supported by investment in advanced hospitals and surgical capacity, while procurement localization and workforce development remain important. Africa shows substantial variation in operating-room resources, blood-management capabilities, regulatory capacity, and supply-chain resilience, making training and dependable distribution central to responsible adoption.

Group Insights: Trade, Regulation, and Procurement Networks

ASEAN markets reflect varied regulatory maturity, healthcare financing, and dependence on imported specialist products, making regional registration strategies and distributor capability important. BRICS countries span major manufacturing and healthcare systems with different approval pathways, public procurement models, and domestic-production priorities. The European Union benefits from coordinated regulatory structures but retains national differences in assessment and purchasing. G7 systems generally place strong weight on clinical evidence, quality systems, pharmacovigilance, and health-economic evaluation. GCC countries are investing in advanced surgical services while emphasizing centralized procurement, reliable import channels, and specialist training. NATO members are diverse but share interest in resilient medical supply chains, trauma readiness, interoperability, and continuity of care.

Country Insights: Diverse Priorities Across Leading Healthcare Markets

Australia emphasizes hospital governance, evidence-based purchasing, and access across geographically dispersed care settings. Brazil combines sophisticated tertiary centers with regional disparities and complex public procurement. Canada places importance on provincial decision-making, hospital formularies, and equitable access. China is strengthening advanced surgical capacity while regulatory, procurement, and domestic-supply considerations remain influential. France, Germany, Italy, and Spain operate within European regulatory frameworks but differ in reimbursement, purchasing, and hospital organization. India’s opportunity is linked to expanding surgical capacity, affordability, and reliable distribution across public and private facilities. Japan and South Korea emphasize advanced clinical practice, quality assurance, and disciplined hospital procurement. Mexico’s adoption is shaped by public-sector purchasing, private healthcare demand, and regional access differences. Russia’s environment is influenced by healthcare-system resilience, localization, and supply continuity. The United Kingdom prioritizes clinical governance, value assessment, and centralized or coordinated purchasing. The United States places strong emphasis on regulatory compliance, hospital value analysis, procedural efficiency, and evidence-based utilization.

Action Priorities for Leaders in Human Fibrin Sealant Kits

Industry leaders should align product design and education with clearly defined surgical use cases, emphasizing preparation simplicity, handling consistency, traceability, and validated storage performance. Clinical strategies should generate robust evidence across relevant specialties and patient groups while documenting outcomes such as hemostatic performance, transfusion avoidance, procedural efficiency, and safety. Commercial teams should segment public, private, and academic buyers by procurement criteria rather than applying a uniform approach. Supply-chain leaders should strengthen temperature-control monitoring, contingency sourcing, local technical support, and post-market surveillance. Responsible AI use should focus on validated workflow assistance, transparent governance, and clinician accountability.

Research Methodology for a Data-Grounded Executive Summary

This summary uses the supplied market definition-human fibrin sealant kits-and organizes findings across clinical practice, regulation, procurement, healthcare infrastructure, supply chains, and technology adoption. Regional, group, and country observations are qualitative and grounded in established differences in healthcare-system organization, regulatory oversight, surgical capacity, and purchasing environments. No market estimates, market shares, forecasts, or company-specific claims are included. A full assessment should triangulate peer-reviewed clinical literature, regulatory documents, hospital procurement standards, reimbursement policies, public health data, adverse-event reporting, and structured interviews with surgeons, pharmacists, operating-room managers, and supply-chain professionals.

Conclusion: Adoption Depends on Evidence, Reliability, and Clinical Fit

Human fibrin sealant kits occupy an important role in modern hemostasis where rapid, localized clot formation and tissue sealing can complement conventional techniques. Their responsible adoption depends less on product availability alone than on clinical appropriateness, validated performance, regulatory compliance, operational reliability, and staff competence. Leaders that connect evidence generation with procedure-specific education, resilient supply chains, transparent governance, and regionally tailored procurement strategies will be better positioned to support safe and effective use across diverse healthcare systems.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of minimally invasive surgeries driving demand for human fibrin sealant kits in cardiovascular and thoracic procedures
5.2. Increasing utilization of autologous fibrin sealant preparations to minimize immunogenicity and regulatory complexity
5.3. Strategic collaborations between biotech companies and academic centers accelerating next generation fibrin sealant innovations
5.4. Integration of precision dual-syringe delivery systems improving application consistency and surgical efficiency in operating rooms
5.5. Heightened focus on health economic assessments and reimbursement strategies impacting fibrin sealant kit adoption in hospitals
5.6. Development of novel hemostatic formulations with enhanced adhesion strength and controlled biodegradation profiles for complex procedures
5.7. Growth of outpatient and ambulatory surgery centers fueling demand for user friendly fibrin sealant kits with rapid setting times
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Fibrin Sealant Kit Market, by Application
8.1. Introduction
8.2. Cardiovascular Surgery
8.3. General Surgery
8.4. Neurosurgery
8.5. Orthopedic Surgery
8.6. Plastic Surgery
9. Human Fibrin Sealant Kit Market, by Product Form
9.1. Introduction
9.2. Frozen Liquid
9.3. Lyophilized Powder
9.3.1. Dual Vial Kits
9.3.2. Single Vial Kits
10. Human Fibrin Sealant Kit Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Freestanding
10.2.2. Hospital Based
10.3. Hospitals
10.3.1. Large Hospitals
10.3.2. Medium Hospitals
10.3.3. Small Hospitals
10.4. Specialty Clinics
11. Human Fibrin Sealant Kit Market, by Sales Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distribution Partners
11.4. Online
12. Human Fibrin Sealant Kit Market, by Patient Group
12.1. Introduction
12.2. Adult
12.3. Pediatric
13. Americas Human Fibrin Sealant Kit Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Human Fibrin Sealant Kit Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Human Fibrin Sealant Kit Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Baxter International Inc.
16.3.2. Johnson & Johnson
16.3.3. Takeda Pharmaceutical Company Limited
16.3.4. CSL Behring
16.3.5. B. Braun Melsungen AG
16.3.6. Octapharma AG
16.3.7. Grifols S.A.
16.3.8. LFB S.A.
16.3.9. Entegrion, Inc.
16.3.10. Haemonetics Corporation
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. HUMAN FIBRIN SEALANT KIT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HUMAN FIBRIN SEALANT KIT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HUMAN FIBRIN SEALANT KIT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HUMAN FIBRIN SEALANT KIT MARKET: RESEARCHAI
FIGURE 26. HUMAN FIBRIN SEALANT KIT MARKET: RESEARCHSTATISTICS
FIGURE 27. HUMAN FIBRIN SEALANT KIT MARKET: RESEARCHCONTACTS
FIGURE 28. HUMAN FIBRIN SEALANT KIT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN FIBRIN SEALANT KIT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY FROZEN LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY FROZEN LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DUAL VIAL KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DUAL VIAL KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SINGLE VIAL KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SINGLE VIAL KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LARGE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY MEDIUM HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY MEDIUM HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SMALL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY DISTRIBUTION PARTNERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 106. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 107. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 108. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 109. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 110. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 111. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 114. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 115. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 116. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 117. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 120. CANADA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 121. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 124. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 125. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 126. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 132. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 133. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 136. MEXICO HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 203. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 204. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 205. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 206. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 207. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 208. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 214. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 215. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 218. GERMANY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 219. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 222. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 223. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 224. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 226. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 227. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 230. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 231. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 234. FRANCE HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 251. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 254. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 255. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 256. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 257. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 260. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 261. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 262. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 263. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 266. ITALY HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 267. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 270. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 271. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 272. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 278. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 279. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 282. SPAIN HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY LYOPHILIZED POWDER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PATIENT GROUP, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA HUMAN FIBRIN SEALANT KIT MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA HUMAN FIBRIN SEALANT KIT

Companies Mentioned

  • B. Braun Melsungen AG
  • Baxter International Inc.
  • CSL Behring
  • Entegrion, Inc.
  • Grifols S.A.
  • Haemonetics Corporation
  • Johnson & Johnson
  • LFB S.A.
  • Octapharma AG
  • Reliance Life Sciences Pvt. Ltd.
  • Takeda Pharmaceutical Company Limited

Related Topics

Related Reports

Fibrin Sealants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Fibrin Sealants - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Fibrin Sealant Market - Global Forecast 2026-2032 - Product Image

Fibrin Sealant Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Fibrin Sealants Market Report 2026 - Product Image

Fibrin Sealants Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Fibrin Sealants - Global Strategic Business Report - Product Image

Fibrin Sealants - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Fibrin Degradation Products Assay Kit Market - Global Forecast 2026-2032 - Product Image

Fibrin Degradation Products Assay Kit Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.